Australia's Respiri eyes best day in 1 mth on UK nod for asthma monitor

Vitasora Health

11/06/2021 03:17

** Shares of medical device maker  RSH.AX  jump as much as
10.1% to A$0.087, on track for best session since May 12
    ** RSH says its product, wheezo, registered and approved for
sale in UK
    ** Wheezo analyses breath sounds for wheezing and helps in
monitoring and managing asthma
    ** Device is due to be launched in the UK in Q4 CY 2021 -
RSH  urn:newsml:reuters.com:*:nASX6Jl7Zx   
    ** Stock down 39.2% this year, as of last close

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))